Drawing for KINLYTIC

USPTO serial 86559631

KINLYTIC

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SPRUILL, DARRYL M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KINLYTIC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard M. LaBarge

RICHARD M. LABARGE Marshall Gerstein Borun233 S Wacker Dr Ste 6300Chicago, IL 60606-6471UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Antithrombotic drugs; Medical preparations for treating pulmonary conditions; thrombolytic drugs; Urokinase preparations for treating blood clots; Urokinase preparations for treating blood clots, administered intravenously; Urokinase preparations for clearing catheters and cannulas; Urokinase preparations for the restoration of patency to intravenous catheter, including central venous catheter, obstructed by clotted blood or fibrin; Urokinase preparations for treating pulmonary embolism; Urokinase preparations for treating the lysis of acute pulmonary emboli and pulmonary emboli accompanied by unstable hemodynamics; Urokinase preparations for treating thrombosis; Urokinase preparations for treating coronary artery thrombosis; Urokinase preparations for treating myocardial infarction; Urokinase preparations for the lysis of thrombi; Urokinase preparations for treating peripheral arterial and graft thromboembolic occlusion; Urokinase preparations for treating deep vein thrombosis; Urokinase preparations for treating pleural effusions; Urokinase preparations for treating peripheral arterial occlusion; Urokinase preparations for treating ischemic stroke; Urokinase preparations for treating lower limb ischemiaACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
May 6, 2019MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 6, 2019ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 10, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 9, 2018EX5GSOU EXTENSION 5 GRANTED—
Oct 4, 2018EXT5SOU EXTENSION 5 FILED—
Oct 4, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 14, 2018EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 13, 2018EX4GSOU EXTENSION 4 GRANTED—
Apr 13, 2018AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 5, 2018EXT4SOU EXTENSION 4 FILED—
Apr 5, 2018EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 4, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 2, 2017EX3GSOU EXTENSION 3 GRANTED—
Oct 2, 2017EXT3SOU EXTENSION 3 FILED—
Oct 2, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 8, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 5, 2017EX2GSOU EXTENSION 2 GRANTED—
Apr 5, 2017EXT2SOU EXTENSION 2 FILED—
Apr 5, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 6, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 4, 2016EX1GSOU EXTENSION 1 GRANTED—
Oct 4, 2016EXT1SOU EXTENSION 1 FILED—
Oct 4, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 5, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Feb 9, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 9, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 20, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 7, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 30, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 29, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 29, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 21, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 2, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 2, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 2, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 15, 2015DOCKASSIGNED TO EXAMINER—
Apr 15, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Apr 15, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 10, 2015ALIEASSIGNED TO LIE—
Apr 6, 2015PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Mar 21, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 13, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance